Showing posts with label Genentech. Show all posts
Showing posts with label Genentech. Show all posts

Monday, September 28, 2009

Medical Communications Scientist at Genentech (job post)

There's a job post on LinkedIn for a Medical Communications Scientist at Genentech. The job requirements specifies a "Doctor of Pharmacy or equivalent with 3-5 years clinical pharmacy practice experience or prior industry experience." Now, when we see the word "equivalent," what exactly does that mean? An RPh? Would an MD or DO qualify? What about a nurse practitioner? A PhD researcher who has extensive experience with drug pharmacology?

In the world of biotechnology and pharmaceuticals (biotech and pharma), there are many job positions that may get filled by a physician, pharmacist, nurse practitioner, nurse, physician assistant, PhD researcher, etc. In other words, it's more critical that you have the necessary scientific and/or clinical knowledge to then translate that into the world of business. To have that level of scientific knowledge, you don't always have to be a physician. In some cases, they may be looking for a physician subspecialist (say an oncologist who has expertise in prostate cancer treatment). In those cases, it will be hard to find any other substitute or "equivalent." However, when you're dealing with more general positions in the biotech/pharma industry, then the requirements may not be so rigid.

After reading the job description on LinkedIn, my conclusion is that other healthcare professionals (beyond pharmacists) may also qualify for this job (remember, this is only my opinion). Maybe the folks at Genentech are specifically only looking for a pharmacist. I really don't know. However, I would not be surprised if the job gets filled by a physician instead of a pharmacist since quite a few physicians are out there looking for non-clinical career opportunities.

The job post is a "LinkedIn Exclusive — this job is available only on LinkedIn." To view the job description on LinkedIn, click here. Speaking of LinkedIn, I hope you'll connect with me: http://www.linkedin.com/in/drjosephkim

Monday, July 27, 2009

Meet some industry Chief Scientific Officers


Would you like to meet some Chief Scientific Officers (CSOs)? What exactly does a CSO do? They keyword here is "strategy." Are you able to integrate scientific strategy with business strategy and communicate things clearly to both internal and external stakeholders? These CSOs are very powerful people in the world of pharma.

According to a recent article on PharmaVOICE, the Chief Scientific Officer "helps set a company's strategy, interacts with investors and board of directors, and helps people understand the science behind new products." It's really a combination of public relations (PR) both externally and internally. They need strong corporate leadership skills that includes a considerable amount of ownership and strategy development.

So who are some of these industry CSOs?
  • Julian Adams, PhD (Infinity Pharmaceuticals)
  • Joseph Bolen, PhD (Millennium, the Takeda Oncology Company)
  • Charles Cantor, PhD (Sequenom)
  • Timothy Clackson, PhD (Ariad Pharmaceuticals)
  • Kevin Judice, PhD (Achaogen)
  • Ruther McKernan, PhD (Pfizer Regenerative Medicine)
  • Martin Petkovich, PhD (Cytochroma)
  • Barry Polisky, PhD (MDRNA)
  • Jasbir Seehra, PhD (Acceleron Pharma)
  • Marc Tessier-Lavigne, PhD (Genentech)
To view the PharmaVOICE article and to meet these CSOs, click here (will open as a PDF).

Monday, April 13, 2009

The Health Industry and the Stock Market

So much is changing in the healthcare industry. Have you spoken with your stock broker? If you're like me, then you probably try to do everything online. I'm a big fan of Online Trading. Why? Because it's so convenient and you can easily make changes easily by getting on a computer and logging in to your favorite Online Broker. It's easy for me since I'm always carring some type of computer around (usually an ultra-mobile PC that is connected to the Internet). The Internet has simplified so many things, including Stock Trading. It's hard to imagine what the world was like before we had the World Wide Web.

Who do you use to trade Stocks, Options, Mutual Funds, ETFs and Fixed Incomes? Pharmaceutical companies are merging, others are downsizing to reduce costs. Pfizer is merging with Wyeth. Schering-Plough is merging with Merck. Roche is aquiring Genentech. This may not be the best time to leave a job in clinical medicine to join the folks in pharma. With all these mergers and acquisitions, Stock Trading must be going crazy these days. The stock market has been in a downhill tumble and no one seems to know what's going to happen in the market. There is so much uncertainly about the current economy. What services or tools do you use for Online Trading?

Friday, February 20, 2009

Raptiva and the FDA


As more stories emerge about progressive multifocal leukoencephalopathy (PML) in patients using the psoriasis drug Raptiva (efalizumab), the FDA has issued a public health advisory. Raptiva is a biologic agent and in October 2008, a black box warning was added to the product label. Raptiva is manufactured by Genentech.